Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Clinical & Translational Immunology|February 23, 2023
Roadmap for understanding mechanisms on how Epstein-Barr virus triggers multiple sclerosis and for translating these discoveries in clinical trialsTobias V Lanz, William H Robinson, Peggy P Ho, et al.Research Square|April 20, 2022
Limited Neutralization of Omicron by Antibodies from the BNT162b2 Vaccination against SARS-CoV-2Tobias V Lanz, R Camille Brewer, Shaghayegh Jahanbani, et al.Frontiers in Immunology|June 28, 2019
Single-Cell High-Throughput Technologies in Cerebrospinal Fluid Research and DiagnosticsTobias V Lanz, Anne-Katrin Pröbstel, Iris Mildenberger, et al.Nature Reviews. Rheumatology|October 10, 2024
Epstein-Barr virus as a potentiator of autoimmune diseasesWilliam H Robinson, Shady Younis, Zelda Z Love, et al.Amino Acids|April 20, 2017
Suppression of Th1 differentiation by tryptophan supplementation in vivoTobias V Lanz, Simon Becker, Soumya R Mohapatra, et al.Biorxiv : the Preprint Server for Biology|September 26, 2025
Sequence-Independent RNA Sensing in Living Mammalian CellsNatalie S Kolber, K Eerik Kaseniit, Tobias V Lanz, et al.Clinical Immunology (Orlando, Fla.)|November 1, 2019
Immunomodulatory receptors are differentially expressed in B and T cell subsets relevant to autoimmune diseaseKatherine A Murphy, Kartik Bhamidipati, Samuel J S Rubin, et al.Nature Immunology|December 1, 2021
BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2R Camille Brewer, Nitya S Ramadoss, Lauren J Lahey, et al.Proceedings of the National Academy of Sciences of the United States of America|March 6, 2026
Multiple molecular mimics in Epstein Barr Nuclear Antigen-1, and the pathogenesis of multiple sclerosisFok Moon Lum, Neda Sattarnezhad, Peggy P Ho, et al.Journal of Neuroimmunology|October 5, 2013
Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant gliomaKatharina Ochs, Felix Sahm, Christiane A Opitz, et al.Pageof 4